Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.3
Document and Entity Information - shares
3 Months Ended
Sep. 30, 2019
Nov. 12, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name DelMar Pharmaceuticals, Inc.  
Entity Central Index Key 0001498382  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2020  
Entity Filer Category Non-accelerated Filer  
Entity Current Reporting Status Yes  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   11,399,700
Entity File Number 001-37823  
Entity Interactive Data Current Yes  
Entity Incorporation State Country Code NV